Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering

Tissue Engineering - Part A

Volumn 17, Issue 23-24, 2011, Pages 2943-2954

  Thein Han, Wahwah ^a   Xu, Hockin H K ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; BONE CEMENT; CALCIUM PHOSPHATE; CELL CULTURE; CELL MEMBRANES; CEMENTS; COLLAGEN; ENDOTHELIAL CELLS; FIBERS; FLOW CYTOMETRY; FLOWCHARTING; SETTING; STEM CELLS; STRENGTH OF MATERIALS; TISSUE;

ALIZARIN RED; BONE MARROW; BONE MINERALS; BONE REGENERATION; BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE CEMENT; CELL ATTACHMENTS; CELL DENSITY; CELL FUNCTIONS; CELL NUMBER; CELL SURFACE MARKER; CELLULAR FUNCTION; COLLAGEN FIBER; COMPOSITE SCAFFOLDS; CRANIOFACIAL; ENDOTHELIAL CELL MARKERS; FLUORESCENCE INTENSITIES; HUMAN UMBILICAL CORD; LOAD-BEARING CAPABILITY; MESENCHYMAL STEM CELL; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; STRESS FIBERS; UMBILICAL CORD STEM CELLS;

SCAFFOLDS (BIOLOGY);

ACTIN; ALIZARIN; ANTHRAQUINONE DERIVATIVE; BONE CEMENT; CALCIUM PHOSPHATE; COLLAGEN; MICROSPHERE; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BONE; BONE DEVELOPMENT; CATTLE; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FLUORESCENCE; GENETICS; HUMAN; IMMUNOPHENOTYPING; MECHANICS; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; STRESS FIBER; TISSUE ENGINEERING; UMBILICAL CORD;

ACTINS; ANIMALS; ANTHRAQUINONES; BONE AND BONES; BONE CEMENTS; CALCIUM PHOSPHATES; CATTLE; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL SURVIVAL; COLLAGEN; FLUORESCENCE; HUMANS; IMMUNOPHENOTYPING; MECHANICAL PHENOMENA; MESENCHYMAL STEM CELLS; MICROSPHERES; OSTEOGENESIS; STRESS FIBERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; UMBILICAL CORD;

EID: 82355184376     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0674     Document Type: Article

References (68)

1. Lavik, E., and Langer, R. Tissue engineering: current state and perspectives. Appl Microbiol Biotech 65, 1, 2004.
2. Mikos, A.G., Herring, S.W., Ochareon, P., Elisseeff, J., Lu, H.H., Kandel, R., Schoen, F.J., Toner, M., Mooney, D., Atala, A., van Dyke, M.E., Kaplan, D., and Vunjak-Novakovic, G. Engineering complex tissues. Tissue Eng 12, 3307, 2006.
3. Johnson, P.C., Mikos, A.G., Fisher, J.P., and Jansen, J.A. Strategic directions in tissue engineering. Tissue Eng 13, 2827, 2007.
4. Mao, J.J., Vunjak-Novakovic, G., Mikos, A.G., and Atala, A. Regenerative Medicine: Translational Approaches and Tissue Engineering, Chapters 1-3. Boston and London: Artech House, 2007.
5. Chatterjee, K., Lin-Gibson, S., Wallace, W.E., Parekh, S.H., Lee, Y.J., Cicerone, M.T., Young, M.F., and Simon, C.G., Jr. The effect of 3D hydrogel scaffold modulus on osteoblast differentiation and mineralization revealed by combinatorial screening. Biomaterials 31, 5051, 2010.
6. Huebsch, N., Arany, P.R., Mao, A.S., Shvartsman, D., Ali, A.O., Bencherif, S.A., Rivera-Feliciano, J., and Mooney, D.J. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 9, 518, 2010.
7. Wahl, D.A., and Czermuszka, J.T. Collagen-hydroxyapatite composites for hard tissue repair. Eur Cell Mater 11, 43, 2006.
8. Praemer, A., Furner, S., and Rice, D.P. Musculoskeletal Conditions in the United States. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1999.
9. Laurencin, C.T., Ambrosio, A.M.A., Borden, M.D., and Cooper, J.A. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng 1, 19, 1999.
10. Meinel, L., Karageorgiou, V., Fajardo, R., Snyder, B., Shinde-Patil, V., Zichner, L., Kaplan, D.L., Langer, R., and Vunjak-Novakovic, G. Bone tissue engineering using human mesenchymal stem cells; effects of scaffold material and medium flow. Ann Biomed Eng 32, 112, 2004.
11. Benoit, D.S.W., Nuttelman, C.R., Collins, S.D., and Anseth, K.S. Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. Biomaterials 27, 6102, 2006.
12. Yao, J., Radin, S., Reilly, G., Leboy, P.S., and Ducheyne, P. Solution-mediated effect of bioactive glass in poly (lacticco-glycolic acid)-bioactive glass composites on osteogenesis of marrow stromal cells. J Biomed Mater Res A 75, 794, 2005.
13. Mao, J.J., Giannobile, W.V., Helms, J.A., Hollister, S.J., Krebsbach, P.H., and Longaker, M.T. Craniofacial tissue engineering by stem cells. J Dent Res 85, 966, 2006.
14. Wang, H.S., Hung, S.C., and Peng, S.T. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22, 1330, 2004.
15. Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M.M., and Davies, J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23, 220, 2005.
16. Can, A., and Karahuseyinoglu, S. Concise review: human umbilical cord stroma with regard to the source of fetusderived stem cells. Stem Cells 25, 2886, 2007.
17. Baksh, D., Yao, R., and Tuan, R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25, 1384, 2007.
18. Bailey, M.M., Wang, L., Bode, C.J., Mitchell, K.E., and Detamore, M.S. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 13, 2003, 2007.
19. Wang, L., Singh, M., Bonewald, L.F., and Detamore, M.S. Signaling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Regen Med 3, 398, 2009.
20. Weiss, M.L., Medicetty, S., Bledsoe, A.R., Rachakatla, R.S., Choi, M., Merchav, S., Luo, Y., Rao, M.S., Velagaleti, G., and Troyer, D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24, 781, 2006.
21. Schneider, R.K., Puellen, A., Kramann, R., Raupach, K., Bornemann, J., Knuechel, R., Pérez-Bouza, A., and Neuss, S. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodeling in three-dimensional collagen scaffolds. Biomaterials 3, 467, 2010.
22. Gauthaman, K., Venugopal, J.R., Yee, F.C., Biswas, A., Ramakrishna, S., and Bongso, A. Osteogenic differentiation of human Wharton's jelly stem cells on nanofibrous substrates in vitro. Tissue Eng A 17, 71, 2011.
23. Jä ger, M., Degistirici, O., Knipper, A., Fischer, J., Sager, M., and Krauspe, R. Bone healing and migration of cord bloodderived stem cells into a critical size femoral defect after xenotransplantation. J Bone Miner Res 22, 1224, 2007.
24. Zhao, L., Burguera, E.F., Xu, H.H.K., Amin, N., Ryou, H., and Arola, D.D. Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds. Biomaterials 31, 840, 2010.
25. Ducheyne, P., and Qiu, Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 20, 2287, 1999.
26. Foppiano, S., Marshall, S.J., Marshall, G.W., Saiz, E., and Tomsia, A.P. The influence of novel bioactive glasses on in vitro osteoblast behavior. J Biomed Mater Res A 71, 242, 2004.
27. Deville, S., Saiz, E., Nalla, R.K., and Tomsia, A.P. Freezing as a path to build complex composites. Science 311, 515, 2006.
28. Reilly, G.C., Radin, S., Chen, A.T., and Ducheyne, P. Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. Biomaterials 28, 4091, 2007.
29. Patel, M., Patel, K.J., Caccamese, J.F., Coletti, D.P., Sauk, J.J., and Fisher, J.P. Characterization of cyclic acetal hydroxyapatite nanocomposites for craniofacial tissue engineering. J Biomed Mater Res A 94, 408, 2010.
30. Parenteau-Bareil, R., Gauvin, R., and Berthod, F. Collagenbased biomaterials for tissue engineering applications. Materials 3, 1863, 2010.
31. Brodie, J.C., Goldie, E., Connel, G., Merry, J., and Grant, M.H. Osteoblast interactions with calcium phosphate ceramics modified by coating with type I collagen. J Biomed Mater Res A 73, 409, 2005.
32. Keeney, M., van den Beucken, J.J., van der Kraan, P.M., Jansen, J.A., and Pandit, A. The ability of collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF165. Biomaterials 31, 2893, 2010.
33. Ghanaati, S.M., Thimm, B.W., Unger, R.E., Orth, C., Kohler, T., Barbeck, M., Muller, R., and Kirkpatrick, C.J. Collagenembedded hydroxyapatite-beta- tricalcium phosphate-silicon dioxide bone substitute granules assist rapid vascularization and promote cell growth. Biomed Mater 5, 1, 2010.
34. Hempel, U., Reinstorf, A., Poppe, M., Fischer, U., Gelinsky, M., Pompe, W., and Wenzel, K.W. Proliferation and differentiation of osteoblasts on Biocement D modified with collagen type I and citric acid. J Biomed Mater Res B 71, 130, 2004.
35. Moreau, J.L., Weir, M.D., and Xu, H.H.K. Self-setting collagen-calcium phosphate bone cement: mechanical and cellular properties. J Biomed Mater Res A 91, 605, 2009.
36. Brown, W.E., and Chow, L.C. A new calcium phosphate water setting cement. In: Brown, P.W., ed. Cements Res Progress. Westerville, OH: American Ceramic Society, 1986, p. 352.
37. Barralet, J.E., Gaunt, T., Wright, A.J., Gibson, I.R., and Knowles, J.C. Effect of porosity reduction by compaction on compressive strength and microstructure of calcium phosphate cement. J Biomed Mater Res B 63, 1, 2002.
38. Bohner, M., and Baroud, G. Injectability of calcium phosphate pastes. Biomaterials 26, 1553, 2005.
39. Habraken, W.J., Liao, H.B., Zhang, Z., Wolke, J.G., Grijpma, D.W., Mikos, A.G., Feijen, J., and Jansen, J.A. In vivo degradation of calcium phosphate cement incorporated into biodegradable microspheres. Acta Biomater 6, 2200, 2010.
40. Friedman, C.D., Costantino, P.D., Takagi, S., and Chow, L.C. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res (Appl Biomater) 43, 428, 1998.
41. Shindo, M.L., Costantino, P.D., Friedman, C.D., and Chow, L.C. Facial skeletal augmentation using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg 119, 185, 1993.
42. Miyamoto, Y., Ishikawa, K., Takechi, M., Toh, T., Yuasa, T., Nagayama, M., and Suzuki, K. Basic properties of calcium phosphate cement containing atelocollagen in its liquid or powder phases. Biomaterials 19, 707, 1998.
43. Reinstorf, A., Ruhnow, M., Gelinsky, M., Pompe, W., Hempel, U., Wenzel, K.W., and Simon, P. Phosphoserine-a convenient compound for modification of calcium phosphate bone cement collagen composites. J Mater Sci Mater Med 15, 451, 2004.
44. Mai, R., Reinstorf, A., Pilling, E., Hlawitschka, M., Jung, R., Gelinsky, M., Schneider, M., Loukota, R., Pompe, W., Eckelt, U., and Stadlinger, B. Histologic study of incorporation and resorption of a bone cement-collagen composite: an in vivo study in the minipig. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105, e9, 2008.
45. Perez, R.A., Ginebra, M.P., and Spector, M. Cell response to collagen-calcium phosphate cement scaffolds investigated for nonviral gene delivery. J Mater Sci Mater Med 22, 887, 2011.
46. Zhao, L., Weir, M.D., and Xu, H.H.K. An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 31, 6502, 2010.
47. Varghese, S., Hwang, N.S., Ferran, A., Hillel, A., Theprungsirikul, P., Canver, A.C., Zhang, Z., Gearhart, J., and Elisseeff, J. Engineering musculoskeletal tissues with human embryonic germ cell derivatives. Stem Cells 28, 765, 2010.
48. Xu, H.H.K., Takagi, S., Quinn, J.B., and Chow, L.C. Fastsetting and anti-washout calcium phosphate scaffolds with high strength and controlled macropore formation rates. J Biomed Mater Res A 68, 725, 2004.
49. Thein-Han, W.W., Shah, J., and Misra, R.D. Superior in vitro biological response and mechanical properties of an implantable nanostructured biomaterial: nanohydroxyapatitesilicone rubber composite. Acta Biomater 5, 2668, 2009.
50. Kim, K., Dean, D., Mikos, A.G., and Fisher, J.P. Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromol 10, 1810, 2009.
51. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt Method. Methods 25, 402, 2001.
52. Xie, J., Baumann, M.J., and McCabe, L.R. Osteoblasts respond to hydroxyapatite surfaces with immediate changes in gene expression. J Biomed Mater Res A 71, 108, 2004.
53. El-Amin, S.F., Lu, H.H., Khan, Y., Burems, J., Mitchell, J., Tuan, R.S., and Laurencin, C.T. Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials 24, 1213, 2003.
54. Scabbia, A., and Trombelli, L. A comparative study on the use of a HA/collagen/chondroitin sulphate biomaterial (Biostite) and a bovine-derived HA xenograft (Bio-Oss) in the treatment of deep intra-osseous defects. J Clin Periodontol 31, 348, 2004.
55. Charriere, G., Bejot, M., Schnitzler, L., Ville, G., and Hartmann, D.J. Reactions to a bovine collagen implant: clinical and immunologic study in 705 patients. J Am Acad Dermatol 21, 1203, 1989.
56. Eaglstein, W.H., Alvarez, O.M., Auletta, M., Leffel, D., Rogers, G.S., Zitelli, J.A., Norris, J.E., Thomas, I., Irondo, M., Fewkes, J., Hardin-Young, J., Duff, R.G., and Sabolinski, M.L. Acute excisional wounds treated with a tissueengineered skin (Apligraf). Dermatol Surg 25, 195, 1999.
57. Carlson, G.A., Dragoo, J.L., Samimi, B., Bruckner, D.A., Bernard, G.W., Hedrick, M., and Benhaim, P. Bacteriostatic properties of biomatrices against common orthopaedic pathogens. Biochem Biophys Res Commun 321, 472, 2004.
58. Martin, G.J., Boden, S.D., Marone, M.A., and Moskovitz, P.A. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12, 179, 1999.
59. Shi, X., Sitharaman, B., Pham, Q.P., Liang, F., Wu, K., Billups, W.E., Wilson, L.J., and Mikos, A.G. Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 28, 4078, 2007.
60. Kuo, C.K., and Ma, P.X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part I. Structure, gelation rate andmechanical properties. Biomaterials 22, 511, 2001.
61. Drury, J.L., Dennis, R.G., and Mooney, D.J. The tensile properties of alginate hydrogels. Biomaterials 25, 3187, 2004.
62. Damien, C.J., and Parsons, J.R. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 2, 187, 1991.
63. Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Matsuura, Y., and Kaibuchi, K. Formation of actin stress fibers and focal adhesions enhanced by rho-kinase. Science 275, 1308, 1997.
64. Grosheva, I., Vittitow, J.L., Goichberg, P., Gabelt, B.T., Kaufman, P.L., Borras, T., Geiger, B., and Bershadsky, A.D. Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells. Exp Eye Res 82, 945, 2006.
65. Viereck, V., Siggelkow, H., Tauber, S., Raddatz, D., Schutze, N., and Hü fner, M. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J Cell Biochem 86, 348, 2002.
66. Wang, Y.H., Liu, Y., Maye, P., and Rowe, D.W. Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog 22, 1697, 2006.
67. Xu, H.H.K., Zhao, L., and Weir, M.D. Stem cell-calcium phosphate constructs for bone engineering. J Dent Res 89, 1482, 2010.
68. Sitharaman, B., Shi, X., Walboomers, X.F., Liao, H., Cuijpers, V., Wilson, L.J., Mikos, A.G., and Jansen, J.A. In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone 43, 362, 2008.